Cargando…

Risk factors for progression of carotid intima-media thickness in patients with systemic lupus erythematosus: protocol for an observational cohort study in China

INTRODUCTION: Accelerated atherosclerosis is a major complication of systemic lupus erythematosus (SLE), and it leads to increased cardiovascular morbidity and mortality in patients with SLE. This study aimed to investigate the natural progression of carotid intima-media thickness (CIMT), and to exa...

Descripción completa

Detalles Bibliográficos
Autores principales: Pang, Haiyu, Ye, Yicong, Ding, Faming, Li, Mengtao, Yang, Xinglin, Yang, Xufei, Wang, Qian, Xu, Dong, Fei, Yunyun, Kang, Lin, Zeng, Xiaofeng, Zhang, Shuyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738958/
https://www.ncbi.nlm.nih.gov/pubmed/31501126
http://dx.doi.org/10.1136/bmjopen-2019-030721
_version_ 1783450873307856896
author Pang, Haiyu
Ye, Yicong
Ding, Faming
Li, Mengtao
Yang, Xinglin
Yang, Xufei
Wang, Qian
Xu, Dong
Fei, Yunyun
Kang, Lin
Zeng, Xiaofeng
Zhang, Shuyang
author_facet Pang, Haiyu
Ye, Yicong
Ding, Faming
Li, Mengtao
Yang, Xinglin
Yang, Xufei
Wang, Qian
Xu, Dong
Fei, Yunyun
Kang, Lin
Zeng, Xiaofeng
Zhang, Shuyang
author_sort Pang, Haiyu
collection PubMed
description INTRODUCTION: Accelerated atherosclerosis is a major complication of systemic lupus erythematosus (SLE), and it leads to increased cardiovascular morbidity and mortality in patients with SLE. This study aimed to investigate the natural progression of carotid intima-media thickness (CIMT), and to examine the risk factors for progression of CIMT and atherosclerotic plaques based on a Chinese SLE cohort. METHODS AND ANALYSIS: Participants were continuously enrolled as outpatients of the Department of Rheumatology in Peking Union Medical College Hospital (PUMCH) from October 2013 to December 2016. Inclusion criteria were as follows: (1) age ≥18 years, (2) fulfilment of clinical classification criteria of SLE and (3) provision of signed written informed consent. Patients with clinically overt coronary artery disease, a history of cardiovascular disease (previous stroke, heart failure, myocardial infarction, angina or symptomatic peripheral artery disease) and malignancy, and pregnant/lactating women were excluded. The primary outcome is progression of CIMT from baseline. A total of 440 patients with SLE will be enrolled. Participants will receive follow-up surveys ~5 years after their baseline visit. A standard structural survey form, including demographic data, medical history, clinical and laboratory assessments and CIMT measurement, is planned for data collection at baseline and follow-up. The risk prediction model for progression of CIMT will be created by using a mixed effect model. ETHICS AND DISSEMINATION: The study protocol was approved by the institutional review board of PUMCH (S-599). Informed consent was obtained from all participants according to the Declaration of Helsinki on Biomedical Research Involving Human Studies. All data will be managed confidentially according to guidelines and legislation. Dissemination will include publication of scientific papers and/or presentations of the study findings at international conferences.
format Online
Article
Text
id pubmed-6738958
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-67389582019-09-25 Risk factors for progression of carotid intima-media thickness in patients with systemic lupus erythematosus: protocol for an observational cohort study in China Pang, Haiyu Ye, Yicong Ding, Faming Li, Mengtao Yang, Xinglin Yang, Xufei Wang, Qian Xu, Dong Fei, Yunyun Kang, Lin Zeng, Xiaofeng Zhang, Shuyang BMJ Open Cardiovascular Medicine INTRODUCTION: Accelerated atherosclerosis is a major complication of systemic lupus erythematosus (SLE), and it leads to increased cardiovascular morbidity and mortality in patients with SLE. This study aimed to investigate the natural progression of carotid intima-media thickness (CIMT), and to examine the risk factors for progression of CIMT and atherosclerotic plaques based on a Chinese SLE cohort. METHODS AND ANALYSIS: Participants were continuously enrolled as outpatients of the Department of Rheumatology in Peking Union Medical College Hospital (PUMCH) from October 2013 to December 2016. Inclusion criteria were as follows: (1) age ≥18 years, (2) fulfilment of clinical classification criteria of SLE and (3) provision of signed written informed consent. Patients with clinically overt coronary artery disease, a history of cardiovascular disease (previous stroke, heart failure, myocardial infarction, angina or symptomatic peripheral artery disease) and malignancy, and pregnant/lactating women were excluded. The primary outcome is progression of CIMT from baseline. A total of 440 patients with SLE will be enrolled. Participants will receive follow-up surveys ~5 years after their baseline visit. A standard structural survey form, including demographic data, medical history, clinical and laboratory assessments and CIMT measurement, is planned for data collection at baseline and follow-up. The risk prediction model for progression of CIMT will be created by using a mixed effect model. ETHICS AND DISSEMINATION: The study protocol was approved by the institutional review board of PUMCH (S-599). Informed consent was obtained from all participants according to the Declaration of Helsinki on Biomedical Research Involving Human Studies. All data will be managed confidentially according to guidelines and legislation. Dissemination will include publication of scientific papers and/or presentations of the study findings at international conferences. BMJ Publishing Group 2019-09-08 /pmc/articles/PMC6738958/ /pubmed/31501126 http://dx.doi.org/10.1136/bmjopen-2019-030721 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Cardiovascular Medicine
Pang, Haiyu
Ye, Yicong
Ding, Faming
Li, Mengtao
Yang, Xinglin
Yang, Xufei
Wang, Qian
Xu, Dong
Fei, Yunyun
Kang, Lin
Zeng, Xiaofeng
Zhang, Shuyang
Risk factors for progression of carotid intima-media thickness in patients with systemic lupus erythematosus: protocol for an observational cohort study in China
title Risk factors for progression of carotid intima-media thickness in patients with systemic lupus erythematosus: protocol for an observational cohort study in China
title_full Risk factors for progression of carotid intima-media thickness in patients with systemic lupus erythematosus: protocol for an observational cohort study in China
title_fullStr Risk factors for progression of carotid intima-media thickness in patients with systemic lupus erythematosus: protocol for an observational cohort study in China
title_full_unstemmed Risk factors for progression of carotid intima-media thickness in patients with systemic lupus erythematosus: protocol for an observational cohort study in China
title_short Risk factors for progression of carotid intima-media thickness in patients with systemic lupus erythematosus: protocol for an observational cohort study in China
title_sort risk factors for progression of carotid intima-media thickness in patients with systemic lupus erythematosus: protocol for an observational cohort study in china
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738958/
https://www.ncbi.nlm.nih.gov/pubmed/31501126
http://dx.doi.org/10.1136/bmjopen-2019-030721
work_keys_str_mv AT panghaiyu riskfactorsforprogressionofcarotidintimamediathicknessinpatientswithsystemiclupuserythematosusprotocolforanobservationalcohortstudyinchina
AT yeyicong riskfactorsforprogressionofcarotidintimamediathicknessinpatientswithsystemiclupuserythematosusprotocolforanobservationalcohortstudyinchina
AT dingfaming riskfactorsforprogressionofcarotidintimamediathicknessinpatientswithsystemiclupuserythematosusprotocolforanobservationalcohortstudyinchina
AT limengtao riskfactorsforprogressionofcarotidintimamediathicknessinpatientswithsystemiclupuserythematosusprotocolforanobservationalcohortstudyinchina
AT yangxinglin riskfactorsforprogressionofcarotidintimamediathicknessinpatientswithsystemiclupuserythematosusprotocolforanobservationalcohortstudyinchina
AT yangxufei riskfactorsforprogressionofcarotidintimamediathicknessinpatientswithsystemiclupuserythematosusprotocolforanobservationalcohortstudyinchina
AT wangqian riskfactorsforprogressionofcarotidintimamediathicknessinpatientswithsystemiclupuserythematosusprotocolforanobservationalcohortstudyinchina
AT xudong riskfactorsforprogressionofcarotidintimamediathicknessinpatientswithsystemiclupuserythematosusprotocolforanobservationalcohortstudyinchina
AT feiyunyun riskfactorsforprogressionofcarotidintimamediathicknessinpatientswithsystemiclupuserythematosusprotocolforanobservationalcohortstudyinchina
AT kanglin riskfactorsforprogressionofcarotidintimamediathicknessinpatientswithsystemiclupuserythematosusprotocolforanobservationalcohortstudyinchina
AT zengxiaofeng riskfactorsforprogressionofcarotidintimamediathicknessinpatientswithsystemiclupuserythematosusprotocolforanobservationalcohortstudyinchina
AT zhangshuyang riskfactorsforprogressionofcarotidintimamediathicknessinpatientswithsystemiclupuserythematosusprotocolforanobservationalcohortstudyinchina